Cargando…
CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
Autores principales: | Shahzad, Faizan, Ur Rehman, Mohammad Ebad, Basit, Jawad, Saeed, Sajeel, Abbas, Khawar, Farhan, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574705/ https://www.ncbi.nlm.nih.gov/pubmed/36263082 http://dx.doi.org/10.1016/j.amsu.2022.104784 |
Ejemplares similares
-
Poliomyelitis in Pakistan: Challenges to polio eradication and future prospects
por: Shabbir, Haroon, et al.
Publicado: (2022) -
Learning from challenges to maternal health during COVID Era; Perspective from Pakistan
por: Fazal, Faizan, et al.
Publicado: (2022) -
Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022) -
The future of robotic surgery for inflammatory bowel diseases
por: Gul, Fahad, et al.
Publicado: (2022) -
Monkeypox: Potentially another pandemic or a mere hoax?
por: Saeed, Sajeel, et al.
Publicado: (2022)